| Elizabeth A Larsen, LICSW | |
|
1900 8th Ave Se, Minot, ND 58701-4935 | |
| (701) 857-5998 | |
| (701) 857-5022 |
| Full Name | Elizabeth A Larsen |
|---|---|
| Gender | Female |
| Speciality | Clinical Social Worker |
| Experience | 31 Years |
| Location | 1900 8th Ave Se, Minot, North Dakota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174603856 | NPI | - | NPPES |
| 19101 | Medicaid | ND |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 1853 (North Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Trinity Hospitals | Minot, ND | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trinity Health | 7911816020 | 287 |
News Archive
The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.
Kenyan social enterprise ZanaAfrica Group is recognized as a leading innovator in global health, education and development with the receipt of the highly selective "Phase II Grand Challenges Exploration" grant, a partnership between Grand Challenges Canada (which is funded by the Government of Canada) and The Bill & Melinda Gates Foundation.
Cryoport, Inc., the leading provider of advanced cryogenic logistics solutions for the life sciences industry, today announced that its validated cryogenic logistics solution will support future clinical trials for Opexa Therapeutics' lead personalized T-cell immunotherapy programs for Multiple Sclerosis ("MS") and Neuromyelitis Optica ("NMO").
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced the closing of a $7.2 million registered direct offering. The amount raised includes $1 million from the Chairman and CEO, Alnoor Shivji, and approximately $500,000 in the aggregate from four other members of the board of directors of WaferGen.
Speaking at the UK National Stem Cell Network conference in York later today, Professor Tessa Holyoake from the University of Glasgow will discuss a brand new approach to treating chronic myeloid leukaemia in which a small number of cancer cells persist despite effective therapy thus preventing cure.
› Verified 2 days ago
| Entity Name | Trinity Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083653752 PECOS PAC ID: 7911816020 Enrollment ID: O20031106000316 |
News Archive
The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.
Kenyan social enterprise ZanaAfrica Group is recognized as a leading innovator in global health, education and development with the receipt of the highly selective "Phase II Grand Challenges Exploration" grant, a partnership between Grand Challenges Canada (which is funded by the Government of Canada) and The Bill & Melinda Gates Foundation.
Cryoport, Inc., the leading provider of advanced cryogenic logistics solutions for the life sciences industry, today announced that its validated cryogenic logistics solution will support future clinical trials for Opexa Therapeutics' lead personalized T-cell immunotherapy programs for Multiple Sclerosis ("MS") and Neuromyelitis Optica ("NMO").
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced the closing of a $7.2 million registered direct offering. The amount raised includes $1 million from the Chairman and CEO, Alnoor Shivji, and approximately $500,000 in the aggregate from four other members of the board of directors of WaferGen.
Speaking at the UK National Stem Cell Network conference in York later today, Professor Tessa Holyoake from the University of Glasgow will discuss a brand new approach to treating chronic myeloid leukaemia in which a small number of cancer cells persist despite effective therapy thus preventing cure.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth A Larsen, LICSW Po Box 5010, Minot, ND 58702-5010 Ph: (701) 418-8000 | Elizabeth A Larsen, LICSW 1900 8th Ave Se, Minot, ND 58701-4935 Ph: (701) 857-5998 |
News Archive
The time needed to genetically sequence the bacteria causing tuberculosis (Mtb) from patient samples has been reduced from weeks to days using a new technique developed by a UCL-led team. This could help health service providers to better treat disease, control transmission of this infection, and monitor outbreaks.
Kenyan social enterprise ZanaAfrica Group is recognized as a leading innovator in global health, education and development with the receipt of the highly selective "Phase II Grand Challenges Exploration" grant, a partnership between Grand Challenges Canada (which is funded by the Government of Canada) and The Bill & Melinda Gates Foundation.
Cryoport, Inc., the leading provider of advanced cryogenic logistics solutions for the life sciences industry, today announced that its validated cryogenic logistics solution will support future clinical trials for Opexa Therapeutics' lead personalized T-cell immunotherapy programs for Multiple Sclerosis ("MS") and Neuromyelitis Optica ("NMO").
WaferGen Biosystems, Inc., a leading developer of state-of-the-art genomic analysis systems, today announced the closing of a $7.2 million registered direct offering. The amount raised includes $1 million from the Chairman and CEO, Alnoor Shivji, and approximately $500,000 in the aggregate from four other members of the board of directors of WaferGen.
Speaking at the UK National Stem Cell Network conference in York later today, Professor Tessa Holyoake from the University of Glasgow will discuss a brand new approach to treating chronic myeloid leukaemia in which a small number of cancer cells persist despite effective therapy thus preventing cure.
› Verified 2 days ago
Mr. James Lein, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1705 4th Ave Nw, Minot, ND 58703 Phone: 701-839-0474 Fax: 701-839-0713 | |
Mr. Orvin G. Lommen, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: #9 Cortland Drive, Minot, ND 58703 Phone: 701-240-7944 Fax: 701-857-8555 | |
Kayla Elaine Durand-goheen, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 21 Main St S Ste 201, Minot, ND 58701 Phone: 701-355-6800 | |
Susan E Stein, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 600 22nd Ave Nw, Minot, ND 58703 Phone: 701-837-6508 Fax: 701-858-1839 | |
Mrs. Laura Howery Siercks, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1015 S Broadway, Suite 18, Minot, ND 58701 Phone: 701-857-8500 Fax: 701-857-8555 | |
Brian Grant Kay, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 194 Missile Ave, Minot, ND 58705 Phone: 701-723-5527 | |
Hayley Marie Alkhafaji, LMSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1015 S Broadway Ste 18, Minot, ND 58701 Phone: 701-857-8500 Fax: 701-857-8555 |